-
The "lone genius" often gets the credit for big ideas, but real-world innovation is a team sport.
-
The Prenetics test, based on research from Oxford University, uses technology that amplifies genetic material from the virus and allows it to be detected quickly, according to the company.
-
Dr. Ian Smith returns to “The Doctors” — this time as the revamped show’s solo host for its 13th season premiering Monday (8 a.m.) on WLNY/Ch. 55. Smith, a physician and best-selling author, co-hosted “The Doctors” during its sixth season (2014-15) and has forged ahead with his TV and writing career; his newest book, “The …
-
Pharmacy giants and tech titans are in a crowded battle to deliver your prescriptions — but a startup coming off a coronavirus-fueled growth spurt thinks it can beat them. Consumers wary of waiting in packed drugstores have turned to digital pharmacy services like Capsule, a New York-based company that’s seen a surge of new customers …
-
Top Beijing officials are promising certain countries, with whom they have strategic partnerships, early access to China’s imminent coronavirus vaccines as they seek to repair their global image following criticism over their failure to contain the initial outbreak of the virus. The countries China is working with to produce vaccines and provide early access include …
-
The U.S. on Wednesday announced an agreement to pay pharmaceutical giant Pfizer and biotech firm BioNTech nearly $2 billion for 100 million doses of their coronavirus vaccine. The Department of Health and Human Services and the Defense Department will acquire 100 million doses of the experimental vaccine under the $1.95 billion deal with Germany-based BioNTech and New York City-based Pfizer. …
-
Researchers at the University of Oxford announced Tuesday that they had found the first proven life-saving coronavirus treatment, after a clinical trial of dexamethasone, a low-cost steroid treatment, cut the risk of death by one-third for coronavirus patients on ventilators and one-fifth for those on oxygen. The study, part of the U.K.’s “Recovery Trial” project …
-
A study that cited worldwide hospital data to warn of higher risks of death and heart problems with taking the antimalarial drug hydroxychloroquine to treat coronavirus is now under scrutiny for faking data. The hydroxychloroquine study, published in two of the world’s leading medical journals — the Lancet and the New England Journal of Medicine …
-
Gilead Sciences’ antiviral drug remdesivir showed signs of helping certain coronavirus patients in a study showing better results from a shorter course of treatment, the company said Monday. People with moderate COVID-19 pneumonia who took a five-day treatment of remdesivir were 65 percent more likely to show “clinical improvement” at day 11 than people who …
-
Broadway actor Nick Cordero, 41, may be in the early stages of waking up from a medically-induced coma after his two month battle with coronavirus. Cordero’s doctors at Cedars-Sinai Medical Center in Los Angeles have seen very small signs of eye movement and tracking — something that he has not been able to do since …
The "lone genius" often gets the credit for big ideas, but real-world innovation is a team sport.
